Cargando…
COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to Coronavirus disease 2019 (COVID-19), is not always confined to the respiratory tract, while patients with can develop neurological manifestations. The patients with multiple sclerosis (MS) pose challenges in this...
Autores principales: | Sadeghmousavi, Shaghayegh, Rezaei, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467844/ https://www.ncbi.nlm.nih.gov/pubmed/32895640 http://dx.doi.org/10.1007/s42399-020-00504-9 |
Ejemplares similares
-
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19
por: Sarzaeim, Mojdeh, et al.
Publicado: (2020) -
Impact of COVID-19 lockdown on progressive multiple sclerosis patients
por: Vercellino, Marco, et al.
Publicado: (2022) -
Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
por: Pourahmad, Ramtin, et al.
Publicado: (2020) -
Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020) -
Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
por: Bonavita, Simona, et al.
Publicado: (2020)